A new test for cervical cancer was found to detect all of the cancers in a randomised clinical screening trial of 15,744 women, outperforming both the current Pap smear and human papillomavirus (HPV) test at a reduced cost, according to a study led by Queen Mary University of London.
The study, published in the International Journal of Cancer, compared a new ‘epigenetics-based’ cervical cancer test with Pap smear and HPV tests, and investigated how well it predicted the development of cervical cancer up to five years in advance in a large study of women aged 25-65 in Canada.
As opposed to checking for patterns in the DNA genetic code itself that are indicative of the HPV virus, the new test looks at the naturally-occurring chemical markers that appear on top of the DNA, making up its ‘epigenetic profile’.
‘An enormous development’
Lead researcher Professor Attila Lorincz from Queen Mary’s Wolfson Institute of Preventive Medicine who also helped develop the world’s first test for HPV in 1988, said: “This is an enormous development. We’re not only astounded by how well this test detects cervical cancer, but it is the first time that anyone has proven the key role of epigenetics in the development of a major solid cancer using data from patients in the clinic. Epigenetic changes are what this cervical cancer test picks up and is exactly why it works so well.
“In contrast to what most researchers and clinicians are saying, we are seeing more and more evidence that it is in fact epigenetics, and not DNA mutations, that drives a whole range of early cancers, including cervical, anal, oropharyngeal, colon, and prostate.”
Screening to prevent cervical cancer is typically done through the Pap smear, which involves the collection, staining and microscopic examination of cells from the cervix. Unfortunately, the Pap smear can detect only around 50 per cent of cervical pre-cancers.
A much more accurate cervical screening method involves testing for the presence of DNA from the human papillomavirus (HPV) – the primary but indirect cause of cervical cancer. There are estimated to be around 10 million women in the UK who are infected by HPV.
However, the HPV test only identifies whether or not women are infected with a cancer-causing HPV, but not their actual risks of cancer, which remain quite low. This causes unnecessary worry for the majority of HPV-infected women who receive a positive result but will eventually clear the virus and not develop the disease.
Predicting a person’s risk of cervical cancer
The new test was significantly better than either the Pap smear or HPV test. It detected 100 per cent of the eight invasive cervical cancers that developed in the 15,744 women during the trial. In comparison, the Pap smear only detected 25 per cent of the cancers, and the HPV test detected 50 per cent.
The study also looked more closely at a subset of 257 HPV-positive women which were representatively selected from the large study. The new test detected 93 per cent of pre-cancerous lesions in those women, compared to 86 per cent detected using a combination of the Pap smear and HPV test, and 61 per cent detected using the Pap smear on its own.
Reducing the number of screening appointments needed
Professor Lorincz added: “This really is a huge advance in how to deal with HPV-infected women and men, numbering in the billions worldwide, and it is going to revolutionise screening.
“We were surprised by how well this new test can detect and predict early cervical cancers years in advance, with 100 per cent of cancers detected, including adenocarcinomas, which is a type of cervical cancer that is very difficult to detect. The new test is much better than anything offered in the UK at present but could take at least five years to be established.”
The authors say that using this test in the clinic would reduce the number of visits to the doctor and screening appointments, as high-grade disease would be detected from the start. They also say that if it was fully implemented, it would be cheaper than the Pap smear.
Learn more: New cervical cancer test has 100 per cent detection rate
The Latest on: Cervical cancer
[google_news title=”” keyword=”cervical cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cervical cancer
- Koreans hand UCI cancer equipment worth sh400 millionon May 7, 2024 at 9:00 am
The Uganda Cancer Institute (UCI) has received cancer screening equipment worth Shillings 400 million, thanks to The Korean Foundation for International Health Care (KOFIH). This donation is ...
- Massive Study Of Cancer In Black Women Announced: 100,000 Subjects Over 30 Yearson May 7, 2024 at 8:39 am
Uterine cancer deaths are highest among black women, according to the National Cancer Institute, and Black women are 60% more likely to die of cervical cancer. Black men and women in the United States ...
- Vaccination can reduce risk of cervical cancer – Medical expertson May 7, 2024 at 8:04 am
A consultant physician with the Kogi State Primary Health Care Development Agency, KSPHCDA, Dr Mary Onoja Alexander has advised that early detection will help prevent cervical cancer among women in ...
- Study sheds light on cancer cell 'tug-of-war'on May 7, 2024 at 8:00 am
Understanding how cancerous cells spread from a primary tumor is important for any number of reasons, including determining the aggressiveness of the disease itself. The movement of cells into the ...
- Bulacan expands Cervical Cancer Vaccination to immunize 21,000 young femaleson May 6, 2024 at 8:53 pm
Plaridel, Pulilan, and Bulakan successfully received the HPV vaccine as part of the local government’s efforts to guard the youth against ...
- Cervical cancer can be eliminated. Alabama is leading the way.on May 6, 2024 at 7:30 pm
Cervical cancer rates in the U.S. have dropped by more than half since the 1970s. Pap tests enable doctors to purge precancerous cells, and a vaccine approved in 2006 has protected a generation of ...
- Having a PCP Important in Cervical Cancer Screening, Especially for LGB Womenon May 6, 2024 at 10:24 am
Lesbian, gay, or bisexual (LGB) women were both less likely to be up-to-date with cervical cancer screening and less likely to have a PCP than their straight counterparts (71% vs 77% and 80% vs 86%, ...
- Cervical cancer remains a significant public health burden – CDA Consulton May 6, 2024 at 10:12 am
Communication for Development and Advocacy Consult Cervical cancer remains a significant public health burden – CDA Consult ...
- Cervical Cancer Screening: US Clinicians Unclear About Best Practiceson May 1, 2024 at 9:48 am
A new survey found that most US clinicians may not be following the American Cancer Society's cervical cancer screening guidelines, which are based on the most up-to-date evidence.
- I Was Told I Had an STI. It Was Actually Cervical Canceron April 24, 2024 at 5:00 pm
Aisha McClellan, 39, from Chapel Hill, North Carolina, was diagnosed with metastatic cervical cancer when she was just 32. Now she spreads awareness about the disease on TikTok. Cervical cancer is ...
via Bing News